These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32533192)

  • 1. A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    Rheumatology (Oxford); 2020 Oct; 59(10):2711-2724. PubMed ID: 32533192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X; Tian F; Wu B; Xu T
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B; Xu T; Li Y; Yin X
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010893. PubMed ID: 30338514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
    Ugurlu S; Ergezen B; Egeli BH; Selvi O; Ozdogan H
    Rheumatology (Oxford); 2020 Dec; 59(12):3892-3899. PubMed ID: 32556219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.
    Sag E; Akal F; Atalay E; Akca UK; Demir S; Demirel D; Batu ED; Bilginer Y; Ozen S
    Rheumatology (Oxford); 2020 Nov; 59(11):3324-3329. PubMed ID: 32306038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
    McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
    Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature.
    Ozgocmen S; Akgul O
    Mod Rheumatol; 2011 Dec; 21(6):684-90. PubMed ID: 21567247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Goker B; Tufan A; Haznedaroglu S
    J Clin Rheumatol; 2020 Jan; 26(1):7-13. PubMed ID: 30048391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
    Hentgen V; Vinit C; Fayand A; Georgin-Lavialle S
    Front Immunol; 2020; 11():971. PubMed ID: 32670263
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of biologic treatments in Familial Mediterranean Fever.
    Akgul O; Kilic E; Kilic G; Ozgocmen S
    Am J Med Sci; 2013 Aug; 346(2):137-41. PubMed ID: 23276893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y; Gezer HH; Duruöz MT
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.
    Erkilet HK; Gezgin Yildirim D; Esmeray P; Söylemezoğlu O
    Pediatr Int; 2023; 65(1):e15588. PubMed ID: 37658625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.
    Arnold DD; Yalamanoglu A; Boyman O
    Front Immunol; 2022; 13():888392. PubMed ID: 35874710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of different drugs in patients with systemic juvenile idiopathic arthritis: A systematic review and network meta-analysis.
    Wang B; Zhang Y; Zhao Z; Ping J; Zhou L; Wang Y; Zhang Y
    Medicine (Baltimore); 2024 May; 103(18):e38002. PubMed ID: 38701278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.
    Sendogan DO; Saritas H; Kumru G; Eyupoglu S; Sadioglu RE; Tuzuner A; Sengul S; Keven K
    Transplant Proc; 2019 Sep; 51(7):2292-2294. PubMed ID: 31400972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.